The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Thalassemia Intermedia (Non-Transfusion-Dependent)

Moderate severity hemoglobinopathy form between thalassemia major and minor that does not require regular transfusions but requires management of additional complications.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Thalassemia Intermedia (Non-Transfusion-Dependent)?

Thalassemia intermedia or non-transfusion-dependent thalassemia (NTDT) is a moderate severity hemoglobinopathy form in which beta-globin synthesis is partially reduced and patients can survive without regular blood transfusions.

Clinically, hemoglobin values are usually in the 7-10 g/dL range. Patients may need transfusions only during infections, pregnancy, surgery or hemolytic crises. However, ineffective erythropoiesis and increased gastrointestinal iron absorption lead to significant iron accumulation over time.

In thalassemia intermedia, non-transfusional iron overload causes complex complications such as liver, cardiac and endocrine organ damage, pulmonary hypertension, extramedullary hematopoiesis masses (paraspinal) and thrombotic events.

Symptoms

Pallor and mild-to-moderate fatigue
Splenomegaly (often prominent)
Mild to moderate jaundice
Leg ulcers
Symptoms of pulmonary hypertension (dyspnea)
Gallstones (pigment stones)
Skeletal changes (skull, face)
Leg edema and exercise intolerance

Risk Factors

Mediterranean and Middle Eastern origin
Consanguineous marriage
Compound heterozygous β/β mutation
Variation in α-globin gene number (modifier)
Post-splenectomy thrombosis
Pregnancy (transfusion need increases)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Progressive decline in Hb
  • New-onset dyspnea (suspicion of pulmonary HT)
  • Leg swelling or signs of heart failure
  • Thrombotic event (DVT, stroke)
  • Abdominal pain (gallstones, extramedullary hematopoiesis)

Treatment Methods

01
Hydroxyurea (HbF inducer, mitigates anemia)
02
Luspatercept (erythropoiesis modulator)
03
Iron chelation (LIC > 5 mg/g dry weight)
04
Folic acid and anticoagulation (when needed)
05
Pulmonary hypertension treatment (sildenafil, ambrisentan)
06
Selective transfusion (pregnancy, surgery, crisis)
07
Splenectomy (last resort in complication management)
08
Annual MRI T2* for cardiac/hepatic iron monitoring

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.